Skip to content
BidSonarBidSonar

Awarded contract

NHS Branded Medicines Framework - Tranche B (London & South of England)

NHS is seeking suppliers for branded medicines across England in two regional lots, with framework agreements commencing September 2026.

Published 9 Jun 2026 · 5 months agoFind a Tender

View on sourceFind a Tender

Award notice and full record on the publisher's site

Closing date

Not published

No closing date published

Contract value

£832,766,796

Pounds sterling

Sector

Healthcare & Medical

Browse related listings

Location

United Kingdom

England

Publisher
UK Cabinet Office
Licence
OGL v3.0
Record ID
ocds-h6vhtk-051a9d

Suppliers

25 suppliers

Lifecycle

Contract awarded. Originally published 5 months ago.

Awarded

9 June 2026

Awarded — no open tender advertised

Brief

NHS Branded Medicines Tranche B procurement opportunity (Reference: CM/PHR/25/5731). Lot 1 covers London and South of England region with a framework agreement period from 1 September 2026 to 31 August 2028, with optional extensions up to 24 months at the Authority's discretion. Lot 2 provides Ustekinumab supply for North of England and Midlands & East regions, running from 1 September 2026 to 31 August 2027, with an optional 12-month extension. Suppliers should note the regional divisions, different contract durations by lot, and extension terms that apply.

Track record

Open panel. Mostly framework call-offs rather than head-to-head competition.

14 awards · 12 winners

In healthcare medical, NHS ENGLAND has awarded 14 contracts to 12 suppliers.

Who wins here

  1. Cipla1× · 7%
  2. Amgen Ltd1× · 7%
  3. IMMUNOIVD AB1× · 7%

+6 more suppliers

Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, NHS SUPPLY CHAIN COORDINATION LIMITED NHSSC SCCL — the field to beat, or your route in as a partner.

Ask an assistant

Add BidSonar to the assistant you already use, then ask it about this notice in plain English.

More from NHS ENGLAND

4 listingsView all

NHS Fidaxomicin Supply Framework

NHS ENGLAND

NHS England invites fidaxomicin suppliers to express interest in a national supply framework with anticipated growth in demand.

PlannedHealthcare & MedicalUnited KingdomPublished 17 Nov 2026

est.£22,320,000

Open in Healthcare & Medical

4 open listingsView all